| Line | Cytokine | Population | Frequency (%) | Sample Size | Location |
|---|---|---|---|---|---|
| 1 | IL-1beta/ -31CC | England South Cytokine | 13.4 | 260 | 51_0_N_1_3_W |
| 2 | IL-1beta/ -31CT | England South Cytokine | 46.3 | 260 | 51_0_N_1_3_W |
| 3 | IL-1beta/ -31TT | England South Cytokine | 40.3 | 260 | 51_0_N_1_3_W |
| 4 | IL-1beta/ -511 CC | England South Cytokine | 33.3 | 260 | 51_0_N_1_3_W |
| 5 | IL-1beta/ -511 CT | England South Cytokine | 51.7 | 260 | 51_0_N_1_3_W |
| 6 | IL-1beta/ -511 TT | England South Cytokine | 14.9 | 260 | 51_0_N_1_3_W |
| 7 | IL-2/ - 330 GG | England South Cytokine | 8.1 | 260 | 51_0_N_1_3_W |
| 8 | IL-2/ - 330 GT | England South Cytokine | 38.1 | 260 | 51_0_N_1_3_W |
| 9 | IL-2/ - 330 TT | England South Cytokine | 53.8 | 260 | 51_0_N_1_3_W |
| 10 | IL-4/ - 590 CC | England South Cytokine | 79.3 | 260 | 51_0_N_1_3_W |
| 11 | IL-4/ - 590 CT | England South Cytokine | 18.8 | 260 | 51_0_N_1_3_W |
| 12 | IL-4/ - 590 TT | England South Cytokine | 1.9 | 260 | 51_0_N_1_3_W |
| 13 | IL-6/ - 174 CC | England South Cytokine | 19.6 | 260 | 51_0_N_1_3_W |
| 14 | IL-6/ - 174 CG | England South Cytokine | 45.1 | 260 | 51_0_N_1_3_W |
| 15 | IL-6/ - 174 GG | England South Cytokine | 35.3 | 260 | 51_0_N_1_3_W |
| 16 | IL-10/ - 592 AA | England South Cytokine | 5.1 | 260 | 51_0_N_1_3_W |
| 17 | IL-10/ - 592 AC | England South Cytokine | 37.3 | 260 | 51_0_N_1_3_W |
| 18 | IL-10/ - 592 CC | England South Cytokine | 57.6 | 260 | 51_0_N_1_3_W |
| 19 | IL-10/ - 819 CC | England South Cytokine | 57.6 | 260 | 51_0_N_1_3_W |
| 20 | IL-10/ - 819 CT | England South Cytokine | 37.3 | 260 | 51_0_N_1_3_W |
| 21 | IL-10/ - 819 TT | England South Cytokine | 5.1 | 260 | 51_0_N_1_3_W |
| 22 | IL-10/ - 1082 AA | England South Cytokine | 20.6 | 260 | 51_0_N_1_3_W |
| 23 | IL-10/ - 1082 AG | England South Cytokine | 53.8 | 260 | 51_0_N_1_3_W |
| 24 | IL-10/ - 1082 GG | England South Cytokine | 25.6 | 260 | 51_0_N_1_3_W |
| 25 | IL-12/ - 1188 AA | England South Cytokine | 60.7 | 260 | 51_0_N_1_3_W |
| 26 | IL-12/ - 1188 AC | England South Cytokine | 33.6 | 260 | 51_0_N_1_3_W |
| 27 | IL-12/ - 1188 CC | England South Cytokine | 5.7 | 260 | 51_0_N_1_3_W |
| 28 | IFNgamma/ 874 AA | England South Cytokine | 31.1 | 260 | 51_0_N_1_3_W |
| 29 | IFNgamma/ 874 AT | England South Cytokine | 48.2 | 260 | 51_0_N_1_3_W |
| 30 | IFNgamma/ 874 TT | England South Cytokine | 20.7 | 260 | 51_0_N_1_3_W |
| 31 | TNFalpha/ - 238 AA | England South Cytokine | 0.0 | 260 | 51_0_N_1_3_W |
| 32 | TNFalpha/ - 238 AG | England South Cytokine | 21.8 | 260 | 51_0_N_1_3_W |
| 33 | TNFalpha/ - 238 GG | England South Cytokine | 78.2 | 260 | 51_0_N_1_3_W |
| 34 | TNFalpha/ - 308 AA | England South Cytokine | 5.9 | 260 | 51_0_N_1_3_W |
| 35 | TNFalpha/ - 308 AG | England South Cytokine | 25.9 | 260 | 51_0_N_1_3_W |
| 36 | TNFalpha/ - 308 GG | England South Cytokine | 68.2 | 260 | 51_0_N_1_3_W |
| 37 | TNFbeta/ 252 AA | England South Cytokine | 41.8 | 260 | 51_0_N_1_3_W |
| 38 | TNFbeta/ 252 AG | England South Cytokine | 37.7 | 260 | 51_0_N_1_3_W |
| 39 | TNFbeta/ 252 GG | England South Cytokine | 20.5 | 260 | 51_0_N_1_3_W |
| 40 | TGFbeta1/codon 25 CC | England South Cytokine | 0.6 | 260 | 51_0_N_1_3_W |
| 41 | TGFbeta1/codon 25 CG | England South Cytokine | 16.3 | 260 | 51_0_N_1_3_W |
| 42 | TGFbeta1/codon 25 GG | England South Cytokine | 83.1 | 260 | 51_0_N_1_3_W |
| 43 | EGF/ 61 AA | England South Cytokine | 39.0 | 260 | 51_0_N_1_3_W |
| 44 | EGF/ 61 AG | England South Cytokine | 42.3 | 260 | 51_0_N_1_3_W |
| 45 | EGF/ 61 GG | England South Cytokine | 18.7 | 260 | 51_0_N_1_3_W |
| 46 | VEGF/ -1154 AA | England South Cytokine | 12.9 | 260 | 51_0_N_1_3_W |
| 47 | VEGF/ -1154 AG | England South Cytokine | 41.5 | 260 | 51_0_N_1_3_W |
| 48 | VEGF/ -1154 GG | England South Cytokine | 45.6 | 260 | 51_0_N_1_3_W |
| 49 | VEGF/ -2578 AA | England South Cytokine | 26.0 | 260 | 51_0_N_1_3_W |
| 50 | VEGF/ -2578 AC | England South Cytokine | 43.2 | 260 | 51_0_N_1_3_W |
| 51 | VEGF/ -2578 CC | England South Cytokine | 30.8 | 260 | 51_0_N_1_3_W |